title: Lipids, 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, and progression of renal failure.
authors.affiliation: Division of Nephrology, C.H. Beauvais and Necker Hospital, France.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Massy
authors.forename: C
authors.initials: C
authors.lastname: Guijarro
authors.forename: M P
authors.initials: MP
authors.lastname: O'Donnell
authors.forename: B L
authors.initials: BL
authors.lastname: Kasiske
authors.forename: W F
authors.initials: WF
authors.lastname: Keane
mesh_terms: D000818:Animals; D018450:Disease Progression; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000473:pathology / Q000503:physiopathology*; D008055:Lipids / Q000502:physiology*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids